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Vancomycin-resistant enterococci (VRE) represent as an immediate 
threat to public health. Since few active compounds are available for 
VRE infections, rapid identification of these isolates are essential. In 
the absence of any report on the genetic relatedness of Enterococcus 
faecalis especially Vancomycin-resistant E. faecalis (VREF) isolates 
in Iran, we undertook this study to characterize these isolates using 
random amplification of polymorphic DNA (RAPD–PCR) genotyp-
ing method. In this study, E. faecalis strains isolated from various 
samples collected from different wards of Children Medical Hospital 
(Tehran, Iran). These isolates were identified by standard laboratory 
procedures and tested for antimicrobial resistance to vancomycin 
and teicoplanin. The genetic similarity of the strains was investigated 
by amplification of the RAPD–PCR.
In our study among 91 E. faecalis isolates, 15 (16%) were 
identified as VREF. The similarity pattern built for E. faeca-
lis isolates by RAPD–PCR, demonstrated the presence of four 
distinct clusters (A, B, C, D). It is of interest to note that 100% 
of VREF isolates belonged to Clusters A, indicating that there 
may have occurred horizontal transmission of the same strain 
between patients. In conclusion, rapid spread of VREF from a 
clonal origin calls for implementation of careful isolation and 
infection control measures. Therefore, environmental control 
by routine disinfection of patient area as well as screening of 
high risk patients and isolation of colonized patients should 
be imposed in order to diminish risk of acquiring nosocomial 
VRE.
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Summary
Introduction
Enterococci, an important cause of clinical infections, 
have emerged as an increasingly important cause of no-
socomial infections in the last decades, being now the 
third to fourth-most prevalent nosocomial pathogen 
worldwide [1]. The emergence and spread of resistance 
to vancomycin as well as other glycopeptide agents like 
teicoplanin among Enterococcus species greatly reduces 
the number of treatment options. In addition, spread of 
vancomycin-resistant enterococci (VRE) represents an 
immediate threat to public health [2, 3].
Since few active compounds are available for VRE 
infections [4], rapid identification of these isolates 
are essential for implementation of control meas-
ures in order to restrict the emerging trouble of these 
strains. 
A variety of typing methods have been used to examine 
clonal relatedness among human VRE isolates [5] but 
little is known about the epidemiology of vancomycin-
resistant Enterococcus faecalis (VREF) [6]. Compari-
sons with respect to the epidemiological concordance 
and the overlap in the data for random amplification 
of polymorphic DNA (RAPD) versus pulsed field gel 
electrophoresis (PFGE) suggested that RAPD analysis 
is well-suited for epidemiological typing of enterococ-
ci [7]. In our previous study, high frequency of VREF as 
high as 16% was reported among hospitalized patients 
at Children’s Medical Center from August 2009 to June 
2010. In the absence of any report on the genetic relat-
edness of E. faecalis especially vancomycin resistant 
E. faecalis (VREF) isolates in Iran, we undertook this 
study to characterize these isolates using RAPD-PCR 
genotyping method.
Methods
The case definition for inclusion in this study was admis-
sion to the Children’s Medical Center hospital (CMC) 
between August 2009 and June 2010, and a culture posi-
tive for E. faecalis at least 48 hours after hospital ad-
mission. No attempt was made to differentiate carriage, 
colonization or clinical infection.
These isolates were identified using standard microbiol-
ogy methods [8] . The Kirby-Bauer disk diffusion meth-
od was used to determine the antimicrobial susceptibil-
ity of E. faecalis isolates to vancomycin and teicoplanin 
according to the Clinical and Laboratory Standards In-
stitute. Isolates with potential vancomycin and teicopla-
nin resistance by this method were confirmed by E-test 
method (AB Biodisk, Solna, Sweden) according to the 
manufacturer’s specification [9]. 
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DNA Extraction
DNA was extracted from VREF isolates using QIAamp 
DNA Mini Kit (QIAGEN) according to the manufac-
turer’s instruction.
Typing of E. faEcalis isolates by RAPD-PCR
The genetic similarity of the strains was investigated by 
amplification of random amplified polymorphic DNA 
(RAPD). RAPD-PCR analysis was performed using 
primer (5’- ACG CGC CCT-3’). The reaction mixture 
(final volume 25 μl) consisted of 19 μl H2O, 2.5 μl 10X 
reaction buffer, 0.75 μl MgCl2 (100 mM), 0.6 μl dNTP 
mixtures (10 mM), 0.2 μl Taq-polymerase (5u/ μl), 1 
μl primer (10mM), 1μl of the DNA. RAPD reactions 
were performed in a thermocycler by using the follow-
ing temperature profile: initial denaturation at 94°C for 
5 min followed by 36°C, 5 min; 72 °C, 5 min; repeat it 
4 time then 94°C, 1 min; 36 °C, 1 min; 72°C, 2 min for 
30 cycles [10]. Amplification products were analyzed by 
electrophoresis in 2% agarose gel with TBE buffer and 
stained with ethidium bromide 0.1%. 
Similarity analysis
The electrophoretic profiles were scored according to 
the presence (1) or absence (0) of a particular band, 
Similarity of all pair-wise combinations of the numeri-
cal profiles was determined by Dice’s coefficient and 
clustered by unweighted pair-group analysis using arith-
metical averages (UPGMA) using the Freetree program 
(0.9.1.50 version). Phylogenetic trees were obtained and 
visualized using the TreeView program (1.30 version).
Results
During the study period, 91 children aged < 1 month to 12 
years old were colonised or infected with E. faecalis.
Patients were hospitalized for a mean of 24 days 
(range 1-105 days).   Twenty-one of the patients were 
hospitalized in urology ward, whereas the others were dis-
tributed in infectious ward (n = 14), surgical ward (n = 12), 
gastroenterology ward (n = 11), nephrology ward (n = 11), 
Neonatal Intensive Care Unit (NICU) (n = 7), Cardiovas-
cular Intensive Care Unit (CICU) (n = 7), oncology (n = 4) 
and Pediatric Intensive Care Unit (PICU) (n = 4). Fifteen 
isolates (16%) were identified as VREF. The MICs to van-
comycin and teicoplanin were ≥ 32 µg ⁄ ml in these isolates.
Fingerprints of DNA fragments by RAPD-PCR were 
recorded. A single dendrogram of similarity was con-
structed for all isolates studied. Figure 1 demonstrated 
the similarity relationships between strains in 4 distinct 
clusters (A-D). Cluster A contained the majority of the 
isolates (n = 37, 41%), while cluster B contained 17 
(19%), cluster C contained 14 (15%), and cluster D con-
tained 23 (25%) of the isolates.
Surprisingly, all VREF isolates belonged to cluster A. 
Patients that were colonized/infected with VREF strains 
were identified in gastroenterology ward (n= 4), infec-
tious ward (n = 3), urology ward (n = 3), CICU (n = 3) 
and NICU (n = 2).
Discussion
In the current study, we have investigated the genotypic 
characteristics of VREF isolates by RAPD method. Al-
though the epidemiology of E. faecium is well described, 
little is known about the epidemiology of vancomycin-
resistant isolates of E. faecalis [6]. Data on the preva-
lence of these strains are scarce in Iran, and to the best 
of our knowledge there is no published information con-
cerning the genetic relatedness of VREF isolates. 
The similarity phylogram built for theses strains, dem-
onstrate the presence of four distinct clusters (A, B, C, 
D). In these clusters, some isolates were allocated in 
groups of higher or lower similarity and most strains 
were discriminated. Clusters A contained the majority of 
the isolates (n = 37, 41%) that were identical and form-
ing one real clone. It is of interest to note that 100% of 
VREF isolates belongs to cluster A, indicating that there 
may have occurred horizontal transmission of the same 
strain between these patients. In our hospital, patients 
may be admitted briefly to a ward that does not match 
the medical care needed due to lack of bed on the ap-
propriate wards. In addition, they might move to other 
wards when the level of care required changes. There-
fore, patient movements may result in the dissemination 
of bacteria around the hospital, especially if proper in-
fection control procedures are not instituted.
Predominance of one clone suggests frequent transfer of 
patients from one ward to another ward. In addition both 
person-to-person transmission and selective antibiotic 
Fig. 1. phylogenetic tree among 91 e. faecalis isolates, construct-
ed by Free Tree “software” and distance Coefficient (dICe), show-
ing relationships, by the UpgmA method.
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pressure can be probable mode of spread [10, 11]. Pa-
tients can remain colonized for prolonged period of time 
from months to years. In contrast to gram-negative bac-
teria, VRE broadly contaminates the environment and 
can remain for a long time; therefore, medical devices 
are commonly positive on wards with VRE patients [12]
and patients might acquire nosocomial VRE from heav-
ily contaminated environment [3]. 
In cluster B, 10 of 17 isolates had 100% similarity, form-
ing four real clones. In cluster C, most of strains were sim-
ilar, forming three real clones. Cluster D with 23 isolates 
had three real clones, which was formed by seven isolates 
and presented the biggest genetic distance among all. Due 
to the genetic distance observed especially in cluster B 
and D, it is probable that the non-VREF isolates in this 
study had diverse origins that may have been due to con-
stant cross transmission of enterococal strains.
Our results are in agreement with those of studies of 
hospital-acquired VRE which indicated clonal dis-
semination as a major mechanism for the spread of iso-
lates [6, 13, 14]. Typing of VREF isolates in the three 
studied hospitals in Spain by PFGE exhibited indistin-
guishable or closely related patterns [15].
Analysis of our results similar to other studies indicate 
vanA gene as common determinant for glycopeptide resist-
ance in Enterococcus spp. [16-18] and clonal dissemina-
tion of VRE [19]. Identification of the source and route of 
dissemination of VRE is helpful for controlling outbreaks. 
Clonal dissemination of vanA gene encoded VRE have 
been reported from other parts of world [19-22]. A study 
from Argentina have shown predominance of one epi-
demic clone carrying vanA gene [20]. Another  molecu-
lar typing of VRE strains from UK revealed cross trans-
mission of predominance VRE  pulsotype with 92% 
containing vanA gene [22]. 
In conclusion, rapid spread of VREF from a clonal ori-
gin calls for implementation of careful isolation and 
infection control measures. Therefore, environmental 
control by routine disinfection of patient area as well as 
screening of high risk patients and isolation of colonized 
patients should be imposed in order to diminish risk of 
acquiring nosocomial VRE.
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